Compare CLOV & AXTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLOV | AXTI |
|---|---|---|
| Founded | 2014 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | 2020 | 1998 |
| Metric | CLOV | AXTI |
|---|---|---|
| Price | $1.98 | $32.24 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 3 |
| Target Price | $3.35 | ★ $24.50 |
| AVG Volume (30 Days) | 5.8M | ★ 6.2M |
| Earning Date | 01-01-0001 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.03 | 35.71 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,371,131,000.00 | $99,361,000.00 |
| Revenue This Year | $41.68 | $41.28 |
| Revenue Next Year | $43.92 | $30.53 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 31.09 |
| 52 Week Low | $1.95 | $1.13 |
| 52 Week High | $4.52 | $30.80 |
| Indicator | CLOV | AXTI |
|---|---|---|
| Relative Strength Index (RSI) | 32.15 | 68.96 |
| Support Level | N/A | $2.56 |
| Resistance Level | $2.78 | N/A |
| Average True Range (ATR) | 0.08 | 3.52 |
| MACD | 0.00 | 0.75 |
| Stochastic Oscillator | 10.42 | 99.02 |
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
AXT Inc is a developer and producer of compound and single element semiconductor substrates, also known as wafers. The dominant substrates used in producing semiconductor chips and other electronic circuits are made from silicon. It is engaged in the design, development, manufacture, and distribution of high-performance compound semiconductor substrates and the sale of materials. The company provides alternative or specialty materials in the form of substrates or wafers, including compound and single-element substrates. Its compound substrates combine indium with phosphorous or gallium with arsenic. Geographically firm has its business presence across the region of Europe, Japan, Taiwan, China, North America, and the Asia Pacific from which China derives its maximum revenue to the company.